Noninvasive monitoring of blood/tissue glucose concentrations has been successfully accomplished in individual diabetic subjects by using near-infrared (NIR) spectroscopy coupled with chemometnc methods. Three different spectrometer configurations were tested: a) a Fouriertransform infrared spectrometer with an indium antimonide detector; b) a grating monochromator equipped with a silicon (Si) array detector, without fiber optics; and C) a grating monochromator equipped with an Si detector, with fiber-optic sampling. NIR spectra were obtained from diabetic subjects by transmission through the finger during a meal-tolerance test. The maximum range of observed plasma glucose concentrations obtained from the bloodsamples was 2.5-27 mmol/L. The NIR spectra were processed by using the chemometnc multivariate calibration methods of partial least squares and principal component regression. of the data obtained with infrared spectroscopy coupled with attenuated-total-reflectance (ATh) sampling or transmission sampling has been used for measuring cholesterol in serum (4) and glucose in whole blood (5-7) and plasma (8-10).
served plasma glucose concentrations obtained from the bloodsamples was 2.5-27 mmol/L. The NIR spectra were processed by using the chemometnc multivariate calibration methods of partial least squares and principal component regression. The best calibration yielded a cross- Noninvasive monitoring of glucose concentrations in the blood or tissue of diabetic patients is a long-soughtafter goal that has only recently become a real possibility. One promising method that may be able to achieve this goal involves applying chemometric methods to the analysis of near-infrared (NIR) spectra obtained in transmission through or by reflection from bloodcontaining tissue3. The use of chemometric tools, such as multivariate calibration, that are capable of simultaneous analysis of all spectral information has increased the sensitivity, precision, accuracy, and reliability of quantitative infrared spectroscopy. The theory and application of these methods to spectroscopic data were recently reviewed (1) (2) (3) . Chemometrics is rapidly being applied to reagentless medical diagnostics.
Multivariate calibration analysis of the data obtained with infrared spectroscopy coupled with attenuated-total-reflectance (ATh) sampling or transmission sampling has been used for measuring cholesterol in serum (4) and glucose in whole blood (5) (6) (7) and plasma (8-10).
Our goal was to determine whether noninvasive mon- itoring of blood/tissue glucose (BT-Glu) concentrations in diabetic subjects was possible by using NIR spectroscopy and multivariate calibration methods. In accomplishing this goal, we investigated several spectrometer configurations that used transmission sampling through the finger of diabetic subjects during mealtolerance tests. Subjects were fed a pancake meal containing 493 kcal, 60 g of protein, 104 g of carbohydrate, and 4 g of fat derived from syrup, margarine, grape juice, and wheat cakes. Whole-blood samples of 5 mL were serially drawn at 10-30-mm intervals during the next 2 h or until a maximum glucose concentration of -22 mmoIJL was measured by hand-held-glucometer monitoring. At that point, 3-5 USP units of regular insulin was administered intravenously to induce a reduction in blood glucose concentration. Sampling was terminated -3 h later when blood monitoring demonstrated a return to promeal glucose concentrations. NIR spectral data through the finger were acquired immediately after each blood sample was drawn and, depending on instrument configuration, were recorded for 1-2 mm to improve the signal-to-noise ratio of the resulting spectra. The resulting distribution of glucose values ranged between --2 and 28 mmol/L. This distribution relates well to the clinically useful range of physiological values. In addition to blood sampling and recording of spectra, surface finger temperatures were monitored in subjects 2 and 3 by using a First Temp Genius Model 3000A pyrometer (Intelligent Medical Systems, Carlsbad, CA). Finger temperatures were measured to ensure that the glucose determinations were not affected by a correlation between glucose concentrations and temperature.
MaterIals and
Three instrument configurations were used in these studies. The first was a Nicolet Instrument Corp. (Madison, WI) Model 800 I'-IR instrument equipped with a tungsten halogen source and a liquid-nitrogen-cooled InSb detector. The beam was directed out of the instrument through the accessory port and focused on the finger in a custom-built optical section. In obtaining air background spectra, we partially closed the iris in the spectrometer to avoid saturating the detector. The second and third instrument configurations used a SPEX Industries (Edison, NJ) Model 270M grating spectrometer equipped with a tungsten-halogen source and a
Photometrics
Ltd. (Tucson, AZ) CCD9000 Si array detector with and without fiber-optic sampling. In the second configuration, the beam was directed with lenses to the finger and to the source. In the third configuration, fiber optics were used both to transmit light to the finger and to collect light from the opposite side of the finger. When fiber optics were not used, the background spectra were acquired by using a cuvette containing whole milk to attenuate the beam and to minimize the influence of water on the spectra. When fiber-optic sampling was used, the background spectra were acquired by using neutral-density filters to attenuate the beam.
We used PLS and PCR calibration methods applied to the spectral data to define an empirical model relating changes in the calibration spectra to the differing reference glucose concentrations of blood samples obtained during the calibration. PLS and PCR are factor-analysis multivariate calibration methods whose properties and relative merits were presented previously (1-3, 11) . Included in these calibration methods are procedures to estimate the uncertainty of predictions resulting from using these models (12).
PLS and PCR calibration models were derived from analysis of an individual subject's plasma glucose concentrations and the corresponding spectral data (5, 12, 13). Both the original absorbance spectral data and first derivatives of the spectra were used in developing the calibration models. First derivatives were obtained simply by taking differences between equally spaced successive absorbance intensities. cases where baselines are smooth but vary widely from one sample to another, first-derivative spectra may be preferable to original spectra for analyses because the derivative spectra doemphasize the influence of the baseline. The results are reported in each case for the method yielding the lowest prediction errors. Cross-validation was used to develop each PLS and PCR calibration model. In the crossvalidation procedure, one sample is omitted from the calibration, and the model is redetermined on the basis of this reduced sample set. The concentration of the omitted sample is then predicted by using the multivariate model. This process is repeated until each sample has been left out of the calibration model. Cross validation is required to determine the optimal size of the calibration model, to obtain good estimates of the predictive ability of the multivariate calibration method, and to reliably detect problems in the calibration data (12). The optimal size of the model was chosen as the model with the fewest number of factors that were within 1 SE of the minimum value of the predicted error sum of squares (12). This method was previously described in more detail relative to our evaluation of JR spectroscopy in the in vitro determination of blood glucose (13).
F-ratio tests (12) were used to verify the quality of each observation (reference glucose value and associated spectrum). This process of outlier detection is based on assessing statistically significant concentration and spectral F ratios calculated during the cross-validation calibration procedure (12). A large concentration F-ratio is probable if there was an error in the reference concentration determination.
A large spectral F-ratio might result from spectrometer error, aberrancies in positioning the finger in the instrument, or the presence of components not present in the other calibration samples. variations rather than glucose concentration differences. The fact that the spectral variations due to glucose are subtle relative to other sources of variation emphasizes the need for multivariate analysis. The baseline variations, although undesirable, either are adequately handled by the multivariate model or can be minimized by modeling first-derivative spectra. Figure   2 shows the cross-validated PLS prediction results for BT-Glu as a function of the corresponding reference glucose concentrations obtained from subject 1. The 41 readings were taken over a range of plasma glucose values from 2.7 to 27.7 mmol/L. The best prediction ability was obtained by applying PLS to absorbance spectra rather than to derivative spectra. PCR yielded slightly poorer prediction ability. Use of the entire frequency range from 870 to 1300 nm resulted in the most precise glucose prediction results. The optimal number of PLS factors was 11, and no samples were detected as outliers; the average absolute error of prodiction obtained by cross-validation was 1.1 mmol/L. RepresentatIve spectra from subjects A: Spectra from subject I taken with the FT-IA spectrometer and lnSb detector; background spectra were taken through air with pallialty closed iris.
In this work, the F-ratio tests demonstrated that each calibration

B:
Spectrafrom subject 2 taken with the grating spectrometer and SI array detector; background spectra were taken through mi0 to attenuate the beam.
C: Spectra from subject 3 taken with the grating spectrometer, SI array detector, and fiber-optic sampling; background spectra were taken throughair with neutral-density filters to attenuate the beam Figure lB shows examples of spectra recorded by the grating spectrometer without fiber-optic sampling for subject 2. We obtained 23 readings over a range of plasma glucose values from 2.9 to 18.4 mmol/L. PCR analysis applied to the first-derivative spectra produced the lowest average absolute error, presumably by reducing the harmful effects of large baseline variations. Only a single background was used for all the spectra to eliminate the possibility that changes in the background milk spectra might influence the results. The data from three samples were identified as outlier data, and these samples were removed from the final analysis. Figure 3A shows a plot of the cross-validated PCRdetermined BT-Glu results obtained for subject 2 as a function of the reference glucose concentrations. The optimal model contained five PCR factors. The absolute average error of prediction for the data shown was 1.6 mmol/L. No consistent correlation between finger temperatures and glucose concentrations was found for subject 2. Figure 1C shows the spectra recorded by the grating spectrometer with fiber-optic sampling. The spectra in parts B and C of Figure 1 have dissimilar shapes because of the different types of background spectra used for calculating the absorbance values. Again, PCR applied to derivative spectra resulted in the lowest prediction errors. One of the 23 samples was detected as a concentration outlier and was removed from the analysis. The PCR-determined BT-Glu data from 22 samples with values ranging from 5.4 to 29.1 mmol/L are plotted in Figure 3B as 
